91Ó°ÊÓ

Treating sinus infections. S?nus infections are common, and doctors commonly treat them with antibiotics. Another treatment is to spray a steroid solution into the nose. A well-designed clinical trial found that these treatments, alone or in combination, do not reduce the severity or the length of sinus infections. 33 The clinical trial was a completely randomized experiment that assigned 240 patients at random among four treatments as follows: (a) The report of this study in the Journal of the American Medical Association describes it as a "double-blind, randomized, placebocontrolled factorial trial." "Factorial" means that the treatments are fomed from more than one factor. What are the factors? What do "double-blind" and "placebo- controlled" mean? (b) If the random assignment of patients to treatments did a good job of eliminating bias, possible lurking variables such as smoking history, asthma, and hay fever should be similar in all four groups. After recording and comparing many such variables, the investigators said that "all showed no significant difference between groups." Explain to someone who knows no statistics what "no significant difference" means. Does it mean that the presence of all these variables was exactly the same in all four treatment groups?

Step by step solution

01

Identify the Factors

In a factorial trial, treatments are combined from more than one factor. In this study, the factors are (1) the use of antibiotics and (2) the use of a steroid solution.

02

Explain Double-blind

"Double-blind" means that neither the participants nor the researchers know which treatment the participants are receiving. This helps prevent bias in assessing the treatment's effectiveness.

03

Explain Placebo-controlled

"Placebo-controlled" means that some patients receive a placebo—a treatment without active ingredients. This acts as a control to compare against the active treatments.

04

Interpret "No Significant Difference"

"No significant difference" means that any variation in patient characteristics among the four treatment groups could be due to random chance rather than the treatment allocation itself. It does not imply that all variables are identical; rather, it suggests that any differences are not statistically meaningful.

Unlock Step-by-Step Solutions & Ace Your Exams!

• Full Textbook Solutions

  Get detailed explanations and key concepts

• Unlimited Al creation

  Al flashcards, explanations, exams and more...

• Ads-free access

  To over 500 millions flashcards

• Money-back guarantee

  We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Double-blind Study

In a double-blind study, neither the participants involved nor the researchers conducting the experiment know who is receiving a particular treatment. This approach is pivotal in clinical trials because it helps eliminate bias. If the researchers and participants are unaware of who gets what treatment, their expectations cannot influence the outcomes, thus maintaining objectivity.

Bias can creep in subconsciously. For instance, if a researcher knows that a participant is receiving the real treatment, they might inadvertently offer more encouragement or attention to that participant. Similarly, participants might behave differently if they know they're getting the actual treatment versus a placebo. By keeping both parties "blind," the study results are more reliable and valid.

• Avoids subjective bias from both researcher and participant sides.
• Helps ensure true effects of treatment are observed.
• Maintains integrity and credibility of the clinical trial results.

Placebo-controlled Trial

In a placebo-controlled trial, some of the participants receive a placebo—a substance with no active therapeutic effect—while others receive the active treatment. This method is essential for comparing the effect of the actual treatment against no treatment at all.

The placebo serves as a baseline that helps researchers determine the treatment's effectiveness. By measuring the difference in outcomes between the participants who received the treatment and those who received the placebo, it's easier to see if the treatment really works.

• Placebos are crucial in identifying true effects.
• They help account for the placebo effect, where patients feel better just by believing they’re being treated.
• Ensures the observed results are due to the treatment itself.

Factorial Experiment

A factorial experiment involves studying more than one factor or variable to see their individual and interactive effects. In clinical trials like the one on sinus infections, treatments are combined from different factors. Here, the treatments involved factors like the use of antibiotics and steroid solutions.

In a factorial design, researchers can test combinations of multiple treatments, which offers more complex data about how various treatments interact with each other. It's a more efficient way of conducting experiments as it allows the study of each factor independently and in combination.

• Investigates multiple treatments simultaneously.
• Can reveal interactions between different treatment factors.
• Offers comprehensive data on treatment effects.

Random Assignment

Random assignment is a process by which participants are randomly allocated to different treatment groups in a study. This process is vital to ensure each participant has an equal chance of being in any group, aiming to eliminate selection bias.

By randomizing, researchers ensure that unforeseen variables, such as age, gender, or lifestyle, are equally distributed among groups. This randomness boosts the likelihood that the treatment itself is the cause of any differences observed and not some other variable.

• Reduces potential for selection bias.
• Achieves balance in participant characteristics across groups.
• Promotes causal inference regarding treatment effects.

Lurking Variables

Lurking variables are factors that are not considered in the study design but could influence the results. These variables can confound the results of an experiment if not properly controlled. In the context of clinical trials, such variables might include a participant's smoking history, asthma, or other health conditions.

The goal is to ensure these variables are evenly distributed across treatment groups, typically achieved through random assignment. When researchers say there is "no significant difference" in lurking variables between groups, they mean that any variation is statistically insignificant, mostly due to chance rather than affecting the outcome.

• Can potentially confound results if not controlled.
• Random assignment helps mitigate their influence.
• Ensures the treatment effect is not skewed by unaccounted factors.